Life Sciences Archives - Page 8 of 32

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

THIS WEEK'S STORIES

Tasca Therapeutics Doses First Patient in Phase 1/2 Trial of CP-383 in Advanced Solid Tumors

September 16, 2025

eClinicalWorks and Sunoh.ai Help Sun River Health Streamline Clinical Documentation Across 50 Sites

September 17, 2025

xFOREST and Axcelead DDP Launch Joint Research on RNA-Targeted Small Molecule Drug Discovery

September 19, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Clean Harbors Study Shows PFAS Incineration Surpasses Latest EPA Standards

Wildlife Acoustics Transitions to Employee Ownership in Maynard, Massachusetts

Oak Hill Bio Publishes Rugonersen Discovery Data in Nucleic Acids Research

Inaugural Stephenson Global Prize Awards $1 Million to Dr. Frank McCormick for Breakthroughs in Pancreatic Cancer Research

Turn Therapeutics CEO and Superbug Survivor Launches Podcast ‘Breaking Brad’ to Spotlight Overlooked Medical Breakthroughs

Most Read

MoldCo Raises $8 Million to Expand Mold Detox Platform and Tackle Widespread Health Crisis

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

Tanner Health, Healthliant Ventures Partner with Incision USA to Enhance Operating Room Performance

EDITOR PICKS

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

THIS WEEK'S STORIES

Tasca Therapeutics Doses First Patient in Phase 1/2 Trial of CP-383 in Advanced Solid Tumors

eClinicalWorks and Sunoh.ai Help Sun River Health Streamline Clinical Documentation Across 50 Sites

xFOREST and Axcelead DDP Launch Joint Research on RNA-Targeted Small Molecule Drug Discovery

POPULAR CATEGORY

ABOUT US

FOLLOW US